These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 30890230)
41. Surface modification of PLGA nanoparticles with biotinylated chitosan for the sustained in vitro release and the enhanced cytotoxicity of epirubicin. Chen H; Xie LQ; Qin J; Jia Y; Cai X; Nan W; Yang W; Lv F; Zhang QQ Colloids Surf B Biointerfaces; 2016 Feb; 138():1-9. PubMed ID: 26638176 [TBL] [Abstract][Full Text] [Related]
42. Novel nanosystem to enhance the antitumor activity of lapatinib in breast cancer treatment: Therapeutic efficacy evaluation. Huo ZJ; Wang SJ; Wang ZQ; Zuo WS; Liu P; Pang B; Liu K Cancer Sci; 2015 Oct; 106(10):1429-37. PubMed ID: 26177628 [TBL] [Abstract][Full Text] [Related]
43. Development and characterization of folate anchored Saquinavir entrapped PLGA nanoparticles for anti-tumor activity. Singh R; Kesharwani P; Mehra NK; Singh S; Banerjee S; Jain NK Drug Dev Ind Pharm; 2015; 41(11):1888-901. PubMed ID: 25738812 [TBL] [Abstract][Full Text] [Related]
44. PEGylated J591 mAb loaded in PLGA-PEG-PLGA tri-block copolymer for targeted delivery: in vitro evaluation in human prostate cancer cells. Moffatt S; Cristiano RJ Int J Pharm; 2006 Jul; 317(1):10-3. PubMed ID: 16713147 [TBL] [Abstract][Full Text] [Related]
45. Target-specific cellular uptake of PLGA nanoparticles coated with poly(L-lysine)-poly(ethylene glycol)-folate conjugate. Kim SH; Jeong JH; Chun KW; Park TG Langmuir; 2005 Sep; 21(19):8852-7. PubMed ID: 16142970 [TBL] [Abstract][Full Text] [Related]
46. Quercetin-loaded poly (lactic-co-glycolic acid)-d-α-tocopheryl polyethylene glycol 1000 succinate nanoparticles for the targeted treatment of liver cancer. Guan X; Gao M; Xu H; Zhang C; Liu H; Lv L; Deng S; Gao D; Tian Y Drug Deliv; 2016 Nov; 23(9):3307-3318. PubMed ID: 27067032 [TBL] [Abstract][Full Text] [Related]
47. Folate-modified PLGA nanoparticles for tumor-targeted delivery of pheophorbide a in vivo. Son J; Yang SM; Yi G; Roh YJ; Park H; Park JM; Choi MG; Koo H Biochem Biophys Res Commun; 2018 Apr; 498(3):523-528. PubMed ID: 29518390 [TBL] [Abstract][Full Text] [Related]
48. Ultrafine PEG-coated poly(lactic-co-glycolic acid) nanoparticles formulated by hydrophobic surfactant-assisted one-pot synthesis for biomedical applications. Chu CH; Wang YC; Huang HY; Wu LC; Yang CS Nanotechnology; 2011 May; 22(18):185601. PubMed ID: 21415469 [TBL] [Abstract][Full Text] [Related]
49. Development and characterization of surface modified PLGA nanoparticles for nasal vaccine delivery: effect of mucoadhesive coating on antigen uptake and immune adjuvant activity. Pawar D; Mangal S; Goswami R; Jaganathan KS Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):550-9. PubMed ID: 23831265 [TBL] [Abstract][Full Text] [Related]
51. Characterisation, cytotoxicity and apoptosis studies of methotrexate-loaded PLGA and PLGA-PEG nanoparticles. Afshari M; Derakhshandeh K; Hosseinzadeh L J Microencapsul; 2014; 31(3):239-45. PubMed ID: 24124881 [TBL] [Abstract][Full Text] [Related]
52. Investigation of PEG-PLGA-PEG nanoparticles-based multipolyplexes for IL-18 gene delivery. Nie Y; Zhang ZR; He B; Gu Z J Biomater Appl; 2012 May; 26(8):893-916. PubMed ID: 21273262 [TBL] [Abstract][Full Text] [Related]
53. Targeted hepatocellular carcinoma therapy: transferrin modified, self-assembled polymeric nanomedicine for co-delivery of cisplatin and doxorubicin. Zhang X; Li J; Yan M Drug Dev Ind Pharm; 2016 Oct; 42(10):1590-9. PubMed ID: 26942448 [TBL] [Abstract][Full Text] [Related]
54. Impact of PEG and PEG-b-PAGE modified PLGA on nanoparticle formation, protein loading and release. Rietscher R; Czaplewska JA; Majdanski TC; Gottschaldt M; Schubert US; Schneider M; Lehr CM Int J Pharm; 2016 Mar; 500(1-2):187-95. PubMed ID: 26784983 [TBL] [Abstract][Full Text] [Related]
55. Poly aspartic acid peptide-linked PLGA based nanoscale particles: potential for bone-targeting drug delivery applications. Jiang T; Yu X; Carbone EJ; Nelson C; Kan HM; Lo KW Int J Pharm; 2014 Nov; 475(1-2):547-57. PubMed ID: 25194353 [TBL] [Abstract][Full Text] [Related]
56. Enhanced cellular uptake of folic acid-conjugated PLGA-PEG nanoparticles loaded with vincristine sulfate in human breast cancer. Chen J; Li S; Shen Q; He H; Zhang Y Drug Dev Ind Pharm; 2011 Nov; 37(11):1339-46. PubMed ID: 21524153 [TBL] [Abstract][Full Text] [Related]
57. Biocompatibility and biodistribution of suberoylanilide hydroxamic acid loaded poly (DL-lactide-co-glycolide) nanoparticles for targeted drug delivery in cancer. Sankar R; Ravikumar V Biomed Pharmacother; 2014 Sep; 68(7):865-71. PubMed ID: 25107842 [TBL] [Abstract][Full Text] [Related]
58. Effect of poly(ethylene glycol) content and formulation parameters on particulate properties and intraperitoneal delivery of insulin from PLGA nanoparticles prepared using the double-emulsion evaporation procedure. Haggag YA; Faheem AM; Tambuwala MM; Osman MA; El-Gizawy SA; O'Hagan B; Irwin N; McCarron PA Pharm Dev Technol; 2018 Apr; 23(4):370-381. PubMed ID: 28285551 [TBL] [Abstract][Full Text] [Related]
59. PLGA-PEG nanoparticles for targeted delivery of the mTOR/PI3kinase inhibitor dactolisib to inflamed endothelium. Gholizadeh S; Kamps JAAM; Hennink WE; Kok RJ Int J Pharm; 2018 Sep; 548(2):747-758. PubMed ID: 29042337 [TBL] [Abstract][Full Text] [Related]
60. Poly(D, L-lactide-co-glycolide) nanoparticles as delivery agents for photodynamic therapy: enhancing singlet oxygen release and photototoxicity by surface PEG coating. Boix-Garriga E; Acedo P; Casadó A; Villanueva A; Stockert JC; Cañete M; Mora M; Sagristá ML; Nonell S Nanotechnology; 2015 Sep; 26(36):365104. PubMed ID: 26293792 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]